Financing ·
Harvard Apparatus Regenerative Technology entered into a $300,000 bridge note with Chairman and CEO Junli He on April…
HRGNHarvard Apparatus Regenerative Technology, Inc.
Harvard Apparatus Regenerative Technology entered into a $300,000 bridge note with Chairman and CEO Junli He on April 13, 2026. The loan accrues interest at an annual fixed rate of 8% and matures on the earlier of April 13, 2027, or the closing of a subsequent capital raise generating at least $5,000,000 in gross proceeds. The note includes optional conversion rights for the lender, standard covenants, and customary events of default. This filing corrects the original report's classification from Item 1.02 to Item 1.01. The company operates in the medical device industry, specializing in regenerative medicine technologies.